Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:29 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 10,300 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: PAIN Clear all

Conditions: Nausea, Abdominal Pain
Interventions: Ondansetron, Dexamethasone; Drug
Lead sponsor: OhioHealth; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Physiological Effect of Drugs, Morphine, Analgesics, Analgesics, Opioid, Central Nervous System Depressants, Narcotics
Interventions: 2% lidocaine with 1:200,000 epinephrine and epidural morphine, 3% 2-chloroprocaine and epidural morphine; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cervical Pain, Pelvic Pain
Interventions: Nitroprusside Gel, Placebo Gel; Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Angina
Interventions: Not listed
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years to 70 Years
Timeline: Started 2007
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Degenerative Spondylolisthesis
Interventions: ART352-L; Biological
Lead sponsor: Ankasa Regenerative Therapeutics, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Los Angeles, California • Rochester, Minnesota • Columbus, Ohio

Conditions: Spinal Cord Injuries, Neuropathic Pain
Interventions: Non-Interactive Virtual Reality Walking, Interactive Virtual Reality Walking; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 64 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Postoperative Pain, Postoperative Edema, Postoperative Ecchymosis, Surgical Wound Healing, Postsurgical Recovery
Interventions: Perioperative photobiomodulation light therapy; Other
Lead sponsor: Elixir MD Inc; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Post-operative Pain
Interventions: Bupivicaine, placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Spinal Surgery
Interventions: Methadone; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Surgical Pain
Interventions: Not listed
Lead sponsor: Defense and Veterans Center for Integrative Pain Management; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Back Pain, Back Pain With Radiation, Pain in Leg, Unspecified
Interventions: Sub-Sensory Stimulation; Other
Lead sponsor: Algos Clinical Development Thomas L. Yearwood, MD, PhD; Other
Eligibility: 22 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Pascagoula, Mississippi

Conditions: Pregnancy, Surgery, Pain
Interventions: Lidocaine Administration; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Spine Fusion, NSAID (Non-Steroidal Anti-Inflammatory Drug), Postoperative Pain
Interventions: Naproxen 500 Mg, Ketorolac, OxyCODONE 5 mg Oral Tablet, Metaxalone 800 MG; Drug
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Pain, Depression
Interventions: Ketamine, Normal saline; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Osteoarthritis, Knee
Interventions: XT-150; Biological
Lead sponsor: Xalud Therapeutics, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Napa, California

Conditions: Pain
Interventions: Oxymorphone; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sacroiliac Joint, Pain, Pelvis
Interventions: SI Screw Removal Surgery, Non-screw removal treatment (non-operative management); Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema, Diabetic Retinopathy
Interventions: Bromfenac Sodium 0.07%, Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly, Propylene Glycol Preservative-free Artificial Tears; Drug
Lead sponsor: Retina Research Institute, LLC; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative, Pain, Back
Interventions: Depo-Medrol 40Mg/Ml Suspension for Injection, Placebo; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetic Neuropathy, Painful
Interventions: Spinal Cord Stimulator (SCS); Device
Lead sponsor: Nevro Corp; Industry
Eligibility: 18 Years and older
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 8
States / cities: Anchorage, Alaska • Ann Arbor, Michigan • West Bloomfield, Michigan + 5 more

Conditions: Pain
Interventions: Ibuprofen 600 mg Immediate Release/Extended Release Caplet; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 613 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 27
States / cities: Hoover, Alabama • Mesa, Arizona • Tucson, Arizona + 24 more

Conditions: Cough, Myalgia, Nasal Obstruction, Sore Throat, Headache, Fatigue, Fever
Interventions: Not listed
Lead sponsor: Cellex, Inc.; Industry
Eligibility: Not listed
Enrollment: 506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 3
States / cities: Birmingham, Alabama • Chicago, Illinois • Baltimore, Maryland

Conditions: Coronary Artery Disease, Angina Pectoris, Chest Pain, Cardiovascular Diseases, CAD, CVD, Coronary Heart Disease, CHD
Interventions: Corus CAD (ASGES); Diagnostic Test
Lead sponsor: CardioDx; Industry
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 9
States / cities: Rutherford, New Jersey • Wake Forest, North Carolina • Youngstown, Ohio + 5 more

Conditions: Chronic Pain
Interventions: Spinal cord stimulation (SCS), Dorsal root ganglion stimulation (DRG); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Timeline: 2019 – 2029
U.S. locations: 30
States / cities: Phoenix, Arizona • Tucson, Arizona • Larkspur, California + 24 more

Search by objective public record fields.

Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department

Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine

The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion

The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina

Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion

Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control

Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery

Characterization of PostOp Pain in Shoulder and Knee Arthroscopy

Sub-Sensory Intraspinal Neurostimulation Therapy

Determination of ED90 of Intrathecal Lidocaine for Adequate Anesthesia for Elective Cervical Cerclage Surgery

Pain Control After Lumbar Spine Fusion

Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression

Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain

Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions

Sacroiliac (SI) Screws: The Effect of SI Screw Removal on Patient-Reported Pain and Functional Outcomes

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

PDN Post Market, Multicenter, Prospective, Global Clinical Study

Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers

Clinical Evaluation of QFlu Combo Test

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator